KOPN Earnings

KOPN reported its FY2025Q3 earnings on 2025-11-12, showcasing a revenue of 12.00M against an estimate of 14.00M, resulting in a -13.88% surprise. The EPS was 0.02, surpassing the expected 0 by 0% . The stock experienced a -0.36% price change on the earnings day and a -14.29% change over the next five days, reflecting market reactions to the results.

Following KOPN's FY2025Q3 earnings announcement on 2025-11-12, the stock price moved by -0.36% on the day of the release. Over the subsequent five days, it saw a -14.29% change. Historically, KOPN's stock price tends to shift by an average of +2.55% in the 10 days leading up to earnings and +5.66% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate KOPN’s annual revenue to reach 13.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -0.19% and EPS estimates Revise Downward by -23.08% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between KOPN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -0.19%, while EPS estimates moved Revise Downward by -23.08% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, KOPN's stock price typically moves by +2.55% in the 10 days before its earnings and +5.66% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 13.00M.

The earnings call highlights strong financial performance with a significant turnaround in net income, reduced SG&A expenses, and a robust cash position. Product development and strategic partnerships, such as with Theon International, indicate potential for future growth. Although there are some uncertainties, like the exact timeline for automation benefits and European orders, the overall sentiment is positive due to the optimistic guidance for future programs and the strategic focus on high-demand sectors like defense and medical.